[15+/-deoxyspergualin, hope for patients with multiple sclerosis?].
Kappos
L
L
Neurologische Universitätsklinik, Kantonsspital Basel.
Theobald
K
K
Hartung
H P
HP
D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology; D006146:Guanidines / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology
D006146:Guanidines; D007166:Immunosuppressive Agents; C037258:gusperimus
15 +/- Deoxyspergualin, eine Hoffnung für MS-Betroffene?